Health News (Reuters)

'Safety net' clinics uneven in delivery of help to quit smoking

(Reuters Health) - Health clinics where low-income people in the U.S. obtain medical care don't always offer help with quitting smoking - and availability of that assistance may vary by patients' ethnicity and insurance, a recent study suggests.

Plan ahead for child's doctor visits, experts say

(Reuters Health) - Parents can make the most of their time at their child's routine pediatrician visits by preparing for each appointment, according to a new resource published in JAMA Pediatrics.

Plan ahead for child's doctor visits, experts say

(Reuters Health) - Parents can make the most of their time at their child's routine pediatrician visits by preparing for each appointment, according to a new resource published in JAMA Pediatrics.

Switzerland weighs relaxing marijuana ban

Switzerland, which permits low potency cannabis but bans most marijuana for recreational use, aims to allow pilot studies on ways to relax its laws, its government said on Wednesday.

Switzerland weighs relaxing marijuana ban

ZURICH (Reuters) - Switzerland, which permits low potency cannabis but bans most marijuana for recreational use, aims to allow pilot studies on ways to relax its laws, its government said on Wednesday.

Anti-gay hostility threatens Indonesia's AIDS battle: activists

Rising government and public hostility toward the lesbian, gay, bisexual and transgender (LGBT) community in Indonesia is threatening the battle against AIDS in the world's largest Muslim-majority country, activists and an official said.

Anti-gay hostility threatens Indonesia's AIDS battle: activists

JAKARTA (Reuters) - Rising government and public hostility toward the lesbian, gay, bisexual and transgender (LGBT) community in Indonesia is threatening the battle against AIDS in the world's largest Muslim-majority country, activists and an official said.

Breast cancer surgeons don't always order genetic testing for patients

(Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests.

Britain moves closer to legalizing medicinal use of cannabis

LONDON (Reuters) - Britain moved a step closer to legalizing the medicinal use of cannabis after a report concluded there are benefits for patients as the government reviews the rules to allow drugs derived from the banned plant.

Sanofi beefs up diabetes pipeline to retrieve success

PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.

U.S. defibrillator probe reduced questionable implantation rate

(Reuters Health) - A U.S. government investigation of allegations that doctors were implanting heart-shocking defibrillators into patients who didn't meet federal guidelines led to a dramatic reduction in the number of implants and may have saved many patients from unnecessary surgery, researchers report in the Journal of the American Medical Association.The 2010 Department of Justice probe involved Medicare recipients, but the new research also documents a comparable drop in defibrillator usage

Minor stroke needs quick medical attention, too

(Reuters Health) - Minor strokes and "mini-strokes," or transient ischemic attacks (TIAs), need early medical attention, just like major strokes, but a public education campaign in the UK had little success convincing the public to act fast after these events.

Sanofi beefing up diabetes pipeline, sees growth returning

PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.

Trump administration names new U.S. drug enforcement chief

(Reuters) - The Trump administration on Monday named a top White House lawyer as the new head of the U.S. Drug Enforcement Administration after the agency's prior acting administrator announced his retirement last month.

Pages